As of the latest Form 4 filed Jun 15, 2026.
What CervoMed Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 19 most recent filings for CRVO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-11 | BOGER JOSHUA S Director | PPurchase | +955K | $3.14 | $3.00M | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-18 | Winton Matthew Chief Commercial and Business | PPurchase | +1.50K | $7.95 | $11.9K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-18 | ELDER WILLIAM ROBERT CFO, GC & Secretary | PPurchase | +2.50K | $8.32 | $20.8K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | Winton Matthew Chief Commercial and Business | PPurchase | +3.50K | $8.43 | $29.5K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | Gregoire Sylvie Director | PPurchase | +10.8K | $8.46 | $91.4K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | Gregoire Sylvie, Director | PPurchase | +10.8K | $8.46 | $91.3K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | ELDER WILLIAM ROBERT CFO, GC & Secretary | PPurchase | +1.00K | $8.45 | $8.45K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | ALAM JOHN J CEO & President | PPurchase | +10.8K | $8.46 | $91.3K | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | ALAM JOHN J, CEO & President | PPurchase | +10.8K | $8.46 | $91.4K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-14 | Gregoire Sylvie Director | PPurchase | +1.69K | $7.55 | $12.8K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-14 | Gregoire Sylvie, Director | PPurchase | +1.71K | $7.57 | $12.9K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-14 | ALAM JOHN J CEO & President | PPurchase | +1.71K | $7.57 | $12.9K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-14 | ALAM JOHN J, CEO & President | PPurchase | +1.69K | $7.55 | $12.8K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-14 | Winton Matthew Chief Commercial and Business | PPurchase | +10.0K | $7.57 | $75.7K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-13 | Gregoire Sylvie Director | PPurchase | +4.45K | $7.51 | $33.4K | No | Form 4 ↗ |
| 2025-11-17 | 2025-11-13 | ALAM JOHN J CEO & President | PPurchase | +4.45K | $7.51 | $33.4K | No | Form 4 ↗ |
| 2025-11-13 | 2025-11-12 | Gregoire Sylvie Director | PPurchase | +5.55K | $7.35 | $40.8K | No | Form 4 ↗ |
| 2025-11-13 | 2025-11-12 | ELDER WILLIAM ROBERT CFO, GC & Secretary | PPurchase | +3.50K | $7.44 | $26.0K | No | Form 4 ↗ |
| 2025-11-13 | 2025-11-12 | ALAM JOHN J CEO & President | PPurchase | +5.55K | $7.35 | $40.8K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CRVO’s full analysis or the market-wide insider trading feed. The tabs above jump to CRVO’s other SEC data.
Source: SEC Form 4 filings for CRVO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.